SCHEMBL14985256

SCHEMBL14985256

C=N[C@H]1CCCC[C@H]1Nc1cnc(C(N)=O)c(Nc2ccc3cccnc3c2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 3/20 0.54
▸ LCK P06239 2/20 0.54
▸ LRRK2 Q5S007 2/20 0.54
▸ JAK2 O60674 2/20 0.54
▸ CDC7 O00311 1/20 0.54
▸ PLK4 O00444 1/20 0.54
▸ CHEK1 O14757 1/20 0.54
▸ PDPK1 O15530 1/20 0.54
▸ DAPK3 O43293 1/20 0.54
▸ DYRK3 O43781 1/20 0.54
▸ ROCK2 O75116 1/20 0.54
▸ RPS6KA5 O75582 1/20 0.54
▸ PRKD3 O94806 1/20 0.54
▸ MAP4K4 O95819 1/20 0.54
▸ PAK4 O96013 1/20 0.54
▸ CHEK2 O96017 1/20 0.54
▸ ABL1 P00519 1/20 0.54
▸ PRKCG P05129 1/20 0.54
▸ FYN P06241 1/20 0.54
▸ CDK1 P06493 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14956590 0.88 LRRK2 (0.70) BTKLCKLRRK2JAK2CDC7
SCHEMBL14956506 0.82 IRAK4 (0.53) BTKLCKLRRK2JAK2CDC7
SCHEMBL14985275 0.77 LRRK2 (0.57) BTKLCKLRRK2JAK2CDC7
SCHEMBL14955736 0.77 LRRK2 (0.67) BTKLCKLRRK2JAK2CDC7
SCHEMBL14985254 0.77 SYK (0.60) BTKLCKLRRK2JAK2CDC7
SCHEMBL14985252 0.75 BTK (0.43) BTKLCKLRRK2JAK2CDC7
SCHEMBL14956176 0.75 SYK (0.57) BTKLCKLRRK2JAK2CDC7
SCHEMBL18925470 0.74 SYK (0.58) LRRK2JAK2ROCK2MAP4K4HCK
SCHEMBL9107397 0.74 SYK (0.68) LRRK2JAK2ROCK2MAP4K4HCK
SCHEMBL23080603 0.74 SYK (0.54) BTKLCKLRRK2JAK2CDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013078466-A1 PYRAZINE KINASE INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2013-05-30 — — WO disclosed
Send feedback